- Home
- XENE vs PRKS Comparison
XENE vs PRKS Comparison
Compare XENE & PRKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- PRKS
- Stock Information
- Founded
- XENE 1996
- PRKS 1959
- Country
- XENE Canada
- PRKS United States
- Employees
- XENE N/A
- PRKS N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XENE Health Care
- PRKS Health Care
- Exchange
- XENE Nasdaq
- PRKS Nasdaq
- Market Cap
- XENE 2.9B
- PRKS 2.8B
- IPO Year
- XENE 2014
- PRKS 2013
- Fundamental
- Price
- XENE $39.36
- PRKS $53.60
- Analyst Decision
- XENE Strong Buy
- PRKS Buy
- Analyst Count
- XENE 11
- PRKS 11
- Target Price
- XENE $52.73
- PRKS $57.73
- AVG Volume (30 Days)
- XENE 747.4K
- PRKS 820.9K
- Earning Date
- XENE 11-11-2025
- PRKS 11-06-2025
- Dividend Yield
- XENE N/A
- PRKS N/A
- EPS Growth
- XENE N/A
- PRKS N/A
- EPS
- XENE N/A
- PRKS 3.77
- Revenue
- XENE $7,500,000.00
- PRKS $1,707,446,000.00
- Revenue This Year
- XENE N/A
- PRKS $0.85
- Revenue Next Year
- XENE $207.88
- PRKS $2.30
- P/E Ratio
- XENE N/A
- PRKS $14.17
- Revenue Growth
- XENE N/A
- PRKS N/A
- 52 Week Low
- XENE $26.74
- PRKS $37.68
- 52 Week High
- XENE $46.00
- PRKS $60.83
- Technical
- Relative Strength Index (RSI)
- XENE 56.70
- PRKS 55.85
- Support Level
- XENE $38.49
- PRKS $53.52
- Resistance Level
- XENE $40.17
- PRKS $55.71
- Average True Range (ATR)
- XENE 1.28
- PRKS 1.49
- MACD
- XENE 0.02
- PRKS 0.15
- Stochastic Oscillator
- XENE 67.55
- PRKS 61.51
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.